|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEW |
1 Department of Physiology and Biophysics
2 Interdisciplinary Biomedical Sciences Program, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, Arkansas 72202, USA
3 Arkansas Children's Nutrition Center, 15 Children's Way, Little Rock, Arkansas 72202, USA
4 Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, California 94945, USA
(Correspondence should be addressed to R C M Simmen; Email: simmenrosalia{at}uams.edu)
Krüppel-like factors (KLFs), of which there are currently 17 known protein members, belong to the specificity protein (Sp) family of transcription factors and are characterized by the presence of Cys2/His2 zinc finger motifs in their carboxy-terminal domains that confer preferential binding to GC/GT-rich sequences in gene promoter and enhancer regions. While previously regarded to simply function as silencers of Sp1 transactivity, many KLFs are now shown to be relevant to human cancers by their newly identified abilities to mediate crosstalk with signaling pathways involved in the control of cell proliferation, apoptosis, migration, and differentiation. Several KLFs act as tumor suppressors and/or oncogenes under distinct cellular contexts, underscoring their prognostic potential for cancer survival and outcome. Recent studies suggest that a number of KLFs can influence steroid hormone signaling through transcriptional networks involving steroid hormone receptors and members of the nuclear receptor family of transcription factors. Since inappropriate sensitivity or resistance to steroid hormone actions underlies endocrine-related malignancies, we consider the intriguing possibility that dysregulation of expression and/or activity of KLF members is linked to the pathogenesis of endometrial and breast cancers. In this review, we focus on recently described mechanisms of actions of several KLFs (KLF4, KLF5, KLF6, and KLF9) in cancers of the mammary gland and uterus. We suggest that understanding the mode of actions of KLFs and their functional networks may lead to the development of novel therapeutics to improve current prospects for cancer prevention and cure.
This article has been cited by other articles:
![]() |
J. M. P. Pabona, Z. Zeng, F. A. Simmen, and R. C. M. Simmen Functional Differentiation of Uterine Stromal Cells Involves Cross-Regulation between Bone Morphogenetic Protein 2 and Kruppel-Like Factor (KLF) Family Members KLF9 and KLF13 Endocrinology, July 1, 2010; 151(7): 3396 - 3406. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kannan-Thulasiraman, D. D. Seachrist, G. H. Mahabeleshwar, M. K. Jain, and N. Noy Fatty Acid-binding Protein 5 and PPAR{beta}/{delta} Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth J. Biol. Chem., June 18, 2010; 285(25): 19106 - 19115. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Simmons, J. M. P. Pabona, Z. Zeng, M. C. Velarde, D. Gaddy, F. A. Simmen, and R. C. M. Simmen Response of adult mouse uterus to early disruption of estrogen receptor-{alpha} signaling is influenced by Kruppel-like factor 9 J. Endocrinol., May 1, 2010; 205(2): 147 - 157. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |